• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Pxr, car and drug metabolism - pp259 - 266

Timothy M. Willson & Steven A. Kliewer

doi:10.1038/nrd753

• Abstract
• Full Text
• PDF (541 KB)

Therapeutic strategies for human amyloid diseases - pp267 - 275

James C. Sacchettini & Jeffery W. Kelly

doi:10.1038/nrd769

• Abstract
• Full Text
• PDF (195 KB)

Obesity therapy: altering the energy intake-and-expenditure balance sheet - pp276 - 286

Vivion E. F. Crowley, Giles S. H. Yeo & Stephen O'Rahilly

doi:10.1038/nrd770

• Abstract
• Full Text
• PDF (1,591 KB)

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer - pp287 - 299

Ricky W. Johnstone

doi:10.1038/nrd772

• Abstract
• Full Text
• PDF (812 KB)

Ethical perspectives on pharmacogenomic profiling in the drug development process - pp300 - 308

Amalia M. Issa

doi:10.1038/nrd771

• Abstract
• Full Text
• PDF (383 KB)